Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1055/s-0040-1714060 http://scihub22266oqcxt.onion/10.1055/s-0040-1714060 32620022!7516390!32620022     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Perinatol 2020 ; 37 (11): 1110-1114 Nephropedia Template TP {{tp|p=32620022|t=2020. Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization |pdf=|usr=}}{{32620022}} gab.com Text Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization JO: Am J Perinatol http://www.kidney.de/pget.php?&tw=1&pmid=32620022 #FOAvip OBJECTIVE: The coronavirus disease 2019 (COVID-19) pandemic has created a need for data regarding the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnant women. After implementing universal screening for COVID-19 in women admitted for delivery, we sought to describe the characteristics of COVID-19 in this large cohort of women. STUDY DESIGN: An observational study of women admitted to labor and delivery units in Kaiser Permanente Southern California (KPSC) hospitals between April 6 and May 11, 2020 who were universally offered testing for SARS-CoV-2 infection (n = 3,963). Hospital inpatient and outpatient physician encounter, and laboratory records were used to ascertain universal testing levels, test results, and medical and obstetrical histories. The prevalence of SARS-CoV-2 infection was estimated from the number of women who tested positive during labor per 100 women delivered. RESULTS: Of women delivered during the study period, 3,923 (99.0%) underwent SARS-CoV-2 testing. A total of 17 (0.43%; 95% confidence interval: 0.23-0.63%) women tested positive, and none of them were symptomatic on admission. There was no difference in terms of characteristics between SARS-CoV-2 positive and negative tested women. One woman developed a headache attributed to COVID-19 3 days postpartum. No neonates had a positive test at 24 hours of life. CONCLUSION: The findings suggest that in pregnant women admitted for delivery between April 6 and May 11, 2020 in this large integrated health care system in Southern California, prevalence of SARS-CoV-2 test positive was very low and all patients were asymptomatic on admission. KEY POINTS: . The prevalence of SARS-CoV-2 infection in a large diverse cohort of term pregnant women was 0.43%.. . 99% of women accepted SARS-CoV-2 screening on admission to labor and delivery.. . All women with positive test results were asymptomatic at the time of testing.. Twit Text FOAVip Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization ????Am J Perinatol http://www.kidney.de/pget.php?&tw=1&pmid=32620022 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32620022 #FOAvip English Wikipedia <ref>{{Cite pmid|32620022}}</ref> Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Large Managed Care Organization #MMPMID32620022 Fassett MJ; Lurvey LD; Yasumura L; Nguyen M; Colli JJ; Volodarskiy M; Gullett JC; Braun D; Fong A; Trivedi N; Bruxvoort K; Chiu V; Getahun D Am J Perinatol 2020[Sep]; 37 (11): 1110-1114 PMID32620022show ga OBJECTIVE: The coronavirus disease 2019 (COVID-19) pandemic has created a need for data regarding the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnant women. After implementing universal screening for COVID-19 in women admitted for delivery, we sought to describe the characteristics of COVID-19 in this large cohort of women. STUDY DESIGN: An observational study of women admitted to labor and delivery units in Kaiser Permanente Southern California (KPSC) hospitals between April 6 and May 11, 2020 who were universally offered testing for SARS-CoV-2 infection (n = 3,963). Hospital inpatient and outpatient physician encounter, and laboratory records were used to ascertain universal testing levels, test results, and medical and obstetrical histories. The prevalence of SARS-CoV-2 infection was estimated from the number of women who tested positive during labor per 100 women delivered. RESULTS: Of women delivered during the study period, 3,923 (99.0%) underwent SARS-CoV-2 testing. A total of 17 (0.43%; 95% confidence interval: 0.23-0.63%) women tested positive, and none of them were symptomatic on admission. There was no difference in terms of characteristics between SARS-CoV-2 positive and negative tested women. One woman developed a headache attributed to COVID-19 3 days postpartum. No neonates had a positive test at 24 hours of life. CONCLUSION: The findings suggest that in pregnant women admitted for delivery between April 6 and May 11, 2020 in this large integrated health care system in Southern California, prevalence of SARS-CoV-2 test positive was very low and all patients were asymptomatic on admission. KEY POINTS: . The prevalence of SARS-CoV-2 infection in a large diverse cohort of term pregnant women was 0.43%.. . 99% of women accepted SARS-CoV-2 screening on admission to labor and delivery.. . All women with positive test results were asymptomatic at the time of testing.. |*Clinical Laboratory Techniques/methods/statistics & numerical data[MESH] |*Coronavirus Infections/diagnosis/epidemiology[MESH] |*Delivery, Obstetric/methods/statistics & numerical data[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/diagnosis/epidemiology[MESH] |*Pregnancy Complications, Infectious/diagnosis/epidemiology[MESH] |Adult[MESH] |Asymptomatic Infections[MESH] |Betacoronavirus/isolation & purification[MESH] |COVID-19[MESH] |COVID-19 Testing[MESH] |California/epidemiology[MESH] |Female[MESH] |Hospitalization/statistics & numerical data[MESH] |Humans[MESH] |Pregnancy[MESH] |Pregnancy Outcome[MESH] |Prevalence[MESH]Universal SARS-Cov-2 Screening in Women Admitted for Delivery in a Lar(epmc).pdf DeepDyve Pubget Overpricing